Clinical Trials: SEARCH[STUDY] TILT[STUDY:STUDY-FIRST-POSTED] ( Thrombocytopenia [STUDY:ALL-FIELDS] )
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 Next Last
#
NCTID/Status
Study
Last Changed
1
NCT02802982
Active, not recruiting
Active, not recruiting
Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates
Conditions: Neonatal Thrombocytopenia
Conditions: Neonatal Thrombocytopenia
January 3, 2019
2
NCT03638817
Recruiting
Recruiting
Perioperative Eltrombopag in Patients With Inherited Thrombocytopenia
Conditions: Thrombocytopenia
Intervention: Eltrombopag
Conditions: Thrombocytopenia
Intervention: Eltrombopag
January 21, 2019
3
NCT02032134
Terminated
Terminated
Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia
Conditions: Thrombocytopenia; Primary Thrombocytopenia,Unspecified; Thrombocytopenia Chemotherapy Induced
Intervention: Transfusion Of Pooled Platelets Cryopreserved In DMSO
Conditions: Thrombocytopenia; Primary Thrombocytopenia,Unspecified; Thrombocytopenia Chemotherapy Induced
Intervention: Transfusion Of Pooled Platelets Cryopreserved In DMSO
October 17, 2017
4
NCT02790567
Completed
Completed
Rapid Diagnosis of Heparin-Induced Thrombocytopenia in Surgical Critically Ill Patients
Conditions: Heparin-induced Thrombocytopenia (HIT)
Intervention: HEP Score, 4Ts Score, ID-PaGIA Test, HIT-Ab(PF4-H) Test
Conditions: Heparin-induced Thrombocytopenia (HIT)
Intervention: HEP Score, 4Ts Score, ID-PaGIA Test, HIT-Ab(PF4-H) Test
June 29, 2016
5
NCT02892630
Recruiting
Recruiting
Immune Thrombocytopenia in Pregnancy
Conditions: Immune Thrombocytopenia; Pregnancy
Intervention: No Intervention
Conditions: Immune Thrombocytopenia; Pregnancy
Intervention: No Intervention
October 18, 2017
6
NCT03059030
Recruiting
Recruiting
Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia
Conditions: Thrombocytopenia; Cirrhosis
Intervention: TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.
Conditions: Thrombocytopenia; Cirrhosis
Intervention: TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.
March 5, 2019
7
NCT03429660
Recruiting
Recruiting
French Adult Primary Immune Thrombocytopenia
Conditions: Thrombocytopenia
Intervention: Medical Information
Conditions: Thrombocytopenia
Intervention: Medical Information
July 10, 2019
8
NCT03326843
Terminated
Terminated
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
Conditions: Thrombocytopenia
Intervention: Avatrombopag 60 Mg
Conditions: Thrombocytopenia
Intervention: Avatrombopag 60 Mg
March 6, 2019
9
NCT03362177
Not yet recruiting
Not yet recruiting
Study of Romiplostim for Chemo-induced Thrombocytopenia in Adults Subjects With Gastrointestinal or Colorectal Cancer
Conditions: Chemotherapy-induced Thrombocytopenia
Intervention: Romiplostim, Placebo
Conditions: Chemotherapy-induced Thrombocytopenia
Intervention: Romiplostim, Placebo
June 20, 2019
10
NCT03448952
Not yet recruiting
Not yet recruiting
Neonatal Thrombocytopenia Among Newborns Admitted to Neonatal Intensive Care Unit
Conditions: Thrombocytopenia Neonatal
Conditions: Thrombocytopenia Neonatal
February 27, 2018
11
NCT03594045
Recruiting
Recruiting
Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)
Conditions: Heparin-induced Thrombocytopenia; Heparin-induced Thrombocytopenia and Thrombosis
Intervention: Apixaban
Conditions: Heparin-induced Thrombocytopenia; Heparin-induced Thrombocytopenia and Thrombosis
Intervention: Apixaban
August 13, 2019
12
NCT02862353
Recruiting
Recruiting
Thrombocytopenia Drug Immune Validation of New Biological Test Diagnostic
Conditions: Thrombocytopenia
Intervention: Blood Sample
Conditions: Thrombocytopenia
Intervention: Blood Sample
July 19, 2019
13
NCT04014166
Recruiting
Recruiting
Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia
Conditions: Thrombocytopenia; Mesenchymal Stem Cells
Intervention: Human Umbilical Cord-derived Mesenchymal Stem Cells (hUC-MSCs)
Conditions: Thrombocytopenia; Mesenchymal Stem Cells
Intervention: Human Umbilical Cord-derived Mesenchymal Stem Cells (hUC-MSCs)
July 7, 2019
14
NCT03492515
Not yet recruiting
Not yet recruiting
Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia
Conditions: Immune Thrombocytopenia
Intervention: Recombinant Human Thrombopoietin, Platelet Concentrate
Conditions: Immune Thrombocytopenia
Intervention: Recombinant Human Thrombopoietin, Platelet Concentrate
April 7, 2018
15
NCT00926354
Terminated
Terminated
Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients
Conditions: Chemotherapy Induced Thrombocytopenia
Intervention: AS101
Conditions: Chemotherapy Induced Thrombocytopenia
Intervention: AS101
June 19, 2011
16
NCT03033199
Unknown status
Unknown status
Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia
Conditions: Immune Thrombocytopenia
Intervention: Probiotic Agent, Dexamethasone
Conditions: Immune Thrombocytopenia
Intervention: Probiotic Agent, Dexamethasone
January 24, 2017
17
NCT03471078
Recruiting
Recruiting
Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers
Conditions: Chemotherapy-induced Thrombocytopenia
Intervention: Avatrombopag, Placebo Oral Tablet
Conditions: Chemotherapy-induced Thrombocytopenia
Intervention: Avatrombopag, Placebo Oral Tablet
June 18, 2019
18
NCT03998059
Recruiting
Recruiting
Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients
Conditions: Thrombocytopenia; Splenectomy
Intervention: Splenectomy
Conditions: Thrombocytopenia; Splenectomy
Intervention: Splenectomy
June 25, 2019
19
NCT02263157
Completed
Completed
Evaluate the Association Between Infection and Thrombocytopenia
Conditions: Thrombocytopenia
Conditions: Thrombocytopenia
October 8, 2014
20
NCT03013114
Unknown status
Unknown status
A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP)
Conditions: Immune Thrombocytopenia
Intervention: Bortezomib
Conditions: Immune Thrombocytopenia
Intervention: Bortezomib
January 5, 2017
21
NCT03324087
Recruiting
Recruiting
Evaluation of HRQoL in Adult With Immune Thrombocytopenia in China
Conditions: Immune Thrombocytopenia
Intervention: HRQoL
Conditions: Immune Thrombocytopenia
Intervention: HRQoL
October 26, 2017
22
NCT01194167
Withdrawn
Withdrawn
Study of Eltrombopag in Platelet Refractory Thrombocytopenia
Conditions: Thrombocytopenia
Intervention: Eltrombopag
Conditions: Thrombocytopenia
Intervention: Eltrombopag
January 8, 2012
23
NCT03554759
Terminated
Terminated
Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure
Conditions: Thrombocytopenia
Intervention: Avatrombopag
Conditions: Thrombocytopenia
Intervention: Avatrombopag
March 6, 2019
24
NCT03848923
Not yet recruiting
Not yet recruiting
Impact of Thrombocytopenia and Platelet Transfusions on Neonatal Bleeding and Inflammation
Conditions: Neonatal Thrombocytopenia
Conditions: Neonatal Thrombocytopenia
July 23, 2019
25
NCT03110887
Completed
Completed
Monitoring Outcome in Neonatal Thrombocytopenia
Conditions: Neonatal Thrombocytopenia; Intraventricular Hemorrhage; Platelet Transfusion
Conditions: Neonatal Thrombocytopenia; Intraventricular Hemorrhage; Platelet Transfusion
August 11, 2017
26
NCT03835598
Recruiting
Recruiting
Post-Operative Thrombocytopenia After Bio-prosthesis Implantation
Conditions: Thrombocytopenia
Conditions: Thrombocytopenia
August 12, 2019
27
NCT01869049
Withdrawn
Withdrawn
The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia
Conditions: Immune Thrombocytopenia
Conditions: Immune Thrombocytopenia
April 18, 2016
28
NCT02717039
Recruiting
Recruiting
Pharmacogenomics of Heparin-Induced Thrombocytopenia
Conditions: Heparin-induced Thrombocytopenia
Intervention: Blood Draw
Conditions: Heparin-induced Thrombocytopenia
Intervention: Blood Draw
January 23, 2019
29
NCT01976104
Completed
Completed
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Conditions: Thrombocytopenia Associated With Liver Disease
Intervention: Avatrombopag (lower Baseline Platelet Count), Placebo (lower Baseline Platelet Count), Avatrombopag (higher Baseline Platelet Count), Placebo (higher Baseline Platelet Count)
Conditions: Thrombocytopenia Associated With Liver Disease
Intervention: Avatrombopag (lower Baseline Platelet Count), Placebo (lower Baseline Platelet Count), Avatrombopag (higher Baseline Platelet Count), Placebo (higher Baseline Platelet Count)
January 29, 2018
30
NCT01972529
Completed
Completed
Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure
Conditions: Thrombocytopenia Associated With Liver Disease
Intervention: Avatrombopag (lower Baseline Platelet Count), Placebo (lower Baseline Platelet Count), Avatrombopag (higher Baseline Platelet Count), Placebo (higher Baseline Platelet Count)
Conditions: Thrombocytopenia Associated With Liver Disease
Intervention: Avatrombopag (lower Baseline Platelet Count), Placebo (lower Baseline Platelet Count), Avatrombopag (higher Baseline Platelet Count), Placebo (higher Baseline Platelet Count)
January 29, 2018
31
NCT02371330
Completed
Completed
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study
Conditions: Thrombocytopenia
Conditions: Thrombocytopenia
November 14, 2017
32
NCT02203422
Withdrawn
Withdrawn
A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）
Conditions: Immune Thrombocytopenia
Intervention: Cyclosporin A, RhTPO
Conditions: Immune Thrombocytopenia
Intervention: Cyclosporin A, RhTPO
April 18, 2016
33
NCT02344979
Unknown status
Unknown status
The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC
Conditions: Thrombocytopenia
Conditions: Thrombocytopenia
January 22, 2015
34
NCT03567798
Completed
Completed
June 25, 2018
35
NCT01000051
Completed
Completed
Eltrombopag for Post Transplant Thrombocytopenia
Conditions: Thrombocytopenia
Intervention: Eltrombopag, Placebo
Conditions: Thrombocytopenia
Intervention: Eltrombopag, Placebo
July 8, 2019
36
NCT02444728
Unknown status
Unknown status
Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE
Conditions: Thrombocytopenia
Intervention: Hydroxychloroquine, Cyclophosphamide, Azathioprine, Methylprednisolone
Conditions: Thrombocytopenia
Intervention: Hydroxychloroquine, Cyclophosphamide, Azathioprine, Methylprednisolone
March 7, 2017
37
NCT02751593
Unknown status
Unknown status
Thrombocytopenia in Gestational Period
Conditions: Immune Thrombocytopenia; Pregnancy
Intervention: Dexamethasone
Conditions: Immune Thrombocytopenia; Pregnancy
Intervention: Dexamethasone
April 21, 2016
38
NCT02052882
Active, not recruiting
Active, not recruiting
Study of Romiplostim for Chemotherapy Induced Thrombocytopenia
Conditions: Isolated Chemotherapy-induced Thrombocytopenia
Intervention: Romiplostim
Conditions: Isolated Chemotherapy-induced Thrombocytopenia
Intervention: Romiplostim
March 6, 2019
39
NCT02227576
Terminated
Terminated
Prevention of Thrombocytopenia in Glioblastoma Patients
Conditions: Thrombocytopenia; Glioblastoma
Intervention: Romiplostim
Conditions: Thrombocytopenia; Glioblastoma
Intervention: Romiplostim
April 23, 2018
40
NCT01568333
Completed
Completed
A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia
Conditions: Immune Thrombocytopenia
Intervention: Decitabine
Conditions: Immune Thrombocytopenia
Intervention: Decitabine
August 17, 2018
41
NCT01349790
Completed
Completed
Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune Thrombocytopenia
Conditions: Primary Thrombocytopenia
Intervention: NewGam
Conditions: Primary Thrombocytopenia
Intervention: NewGam
May 4, 2017
42
NCT03937154
Not yet recruiting
Not yet recruiting
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
Conditions: Chemotherapy-induced Thrombocytopenia
Intervention: Romiplostim, Placebo
Conditions: Chemotherapy-induced Thrombocytopenia
Intervention: Romiplostim, Placebo
May 2, 2019
43
NCT01438840
Completed
Completed
Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)
Conditions: Chronic Thrombocytopenia; Immune Thrombocytopenia
Intervention: Avatrombopag, Placebo, Standard Of Care
Conditions: Chronic Thrombocytopenia; Immune Thrombocytopenia
Intervention: Avatrombopag, Placebo, Standard Of Care
January 9, 2018
44
NCT02227693
Completed
Completed
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia
Conditions: Thrombocytopenia Associated With Chronic Liver Disease
Intervention: Avatrombopag, Placebo
Conditions: Thrombocytopenia Associated With Chronic Liver Disease
Intervention: Avatrombopag, Placebo
October 17, 2018
45
NCT02487563
Unknown status
Unknown status
Prospective Study of Patients With Thrombocytopenia Following HSCT
Conditions: Thrombocytopenia; Hematologic Diseases
Intervention: Decitabine, RhTPO
Conditions: Thrombocytopenia; Hematologic Diseases
Intervention: Decitabine, RhTPO
June 29, 2015
46
NCT03201848
Recruiting
Recruiting
The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia
Conditions: Immune Thrombocytopenia
Intervention: Placebo, Huaiqihuang Granule
Conditions: Immune Thrombocytopenia
Intervention: Placebo, Huaiqihuang Granule
July 11, 2017
47
NCT03701217
Recruiting
Recruiting
Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML
Conditions: Eltrombopag; Thrombocytopenia; Acute Myeloid Leukemia
Intervention: Eltrombopag
Conditions: Eltrombopag; Thrombocytopenia; Acute Myeloid Leukemia
Intervention: Eltrombopag
October 7, 2018
48
NCT00748839
Completed
Completed
Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive Clinical
Conditions: Heparin-induced Thrombocytopenia
Conditions: Heparin-induced Thrombocytopenia
November 22, 2012
49
NCT01345214
Terminated
Terminated
A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia
Conditions: Chemotherapy-Induced Thrombocytopenia
Intervention: ONO-7746
Conditions: Chemotherapy-Induced Thrombocytopenia
Intervention: ONO-7746
March 31, 2014
50
NCT00456326
Completed
Completed
Heparin-Induced Thrombocytopenia Registry
Conditions: Heparin-Induced Thrombocytopenia
Conditions: Heparin-Induced Thrombocytopenia
February 12, 2008
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 Next Last
Last Updated
The last updated date is the most recent date when changes to a clinical trial were
submitted to ClinicalTrials.gov. There is often a delay of a few days before the
updated trial is available on the clinical trials website.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
First Received
The first received date is the date when the clinical trial was first submitted
to ClinicalTrials.gov. There is often a delay of a few days before the
trial is available on the clinical trials website.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Safety Issue
If selected, restricts search results to those studies which have
an outcome measure designated as a safety issue. Note that this is a
poor estimate of the safety of a treatment or intervention, but it is
all we have now.
Funded By
Studies are supported by one or more organizations called sponsors.
Support includes contributions of facilities, expertise, and/or financial resources.
All sponsors in the database have been assigned one of the following organization types:
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
Study Phase
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions
that study is seeking to answer:
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Age Group
Studies may be designed for participants of particular ages:
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Gender
Searches can be restricted to studies which accept female or male participants.
Location Terms
If you are interested in a specific city (such as Los Angeles) or facility
name (such as the Mayo Clinic), enter it as a location term. Not all studies
include this level of detail, but if they do, this will find them.
Countries and States
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state.
Study IDs
Each trial is assigned one or more identification numbers by the institute, agency,
or organization sponsoring the trial. In addition, clinical trials assigns a
unique NCT identifier of the form NCTxxxxxxxx where each x is a numeric digit.
Use this box to search for a trial by NCT identifier or any other study
identification numbers.
Examples:
Examples:
NCT00001789
97-h-0197
ia0006
actg 076
97-h-0197
ia0006
actg 076
Sponsor (Lead)
Use this box to specify the name of an institute, organization, or company that is
conducting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Sponsor/Collaborators
Use this box to specify institutes, organizations, or companies that are
conducting or otherwise supporting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Outcome Measures
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Outcome measures are used to evaluate trial results. For example, an obesity treatment
might be evaluated by a measure of weight loss after 6 months. Measures can also be used
to quantify side effects, such as number of myocardial infarctions,
number of patients with heart arrhythmia, number of suicides, etc.
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Interventions
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied.
Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Conditions
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov,
conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Study Type
There are three types of studies available in ClinicalTrials.gov:
There are three types of studies available in ClinicalTrials.gov:
Interventional:
Observational:
Expanded Access:
Studies where individuals are assigned to receive specific interventions.
Participants may receive diagnostic, therapeutic or other types of interventions.
Assignment of the intervention may or may not be random.
Individuals are tracked and biomedical and/or health outcomes are assessed.
Observational:
Studies without an intervention.
Studies where biomedical and/or health outcomes are assessed in a pre-defined group of individuals.
Participants may receive diagnostic, therapeutic, or other interventions, but the investigator
does not assign specific interventions to the participants of the study.
Expanded Access:
Records describing the procedure for obtaining an experimental drug or device for patients who
are failing on currently available treatments for their condition and also are unable to
participate in ongoing clinical trials. Expanded Access records are used to register all
types of non-protocol access to experimental treatments, including protocol exception,
single-patient IND, treatment IND, compassionate use, emergency use, continued access and parallel track.
Study Results
Searches can be restricted to studies with or without results.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
Recruitment Status
Also known as Enrollment Status.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Search Terms
Use this box to specify general search terms found anywhere in the trial record.
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Help for Searching clinical trials
Help Topics:
Basic Search:
On the Basic Search page, enter a word or word(s) that you want to use to find studies.
These may include diseases, interventions, and/or locations.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
Use of a Pacemaker Following a Heart Attack.
higher than the study,
Heart Defects and Transient Ischemic Attacks
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Advanced Search:
Many searches are a single term and can be performed with a few words in the
search box. But, sometimes you need more control. Click on the Advanced Search tab
(if starting a new search) or Refine Search tab (if modifying an existing search)
to show additional search fields.
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Recruitment:
Interventions:
Outcomes Measures:
Sponsor/Collaborators:
Sponsor (Lead):
Study IDs:
Country/State:
Location Terms:
Gender:
Age Group:
Phase:
Funded By:
Safety Issue:
First Received:
Last Updated:
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Performs a general search in all sections of the study record, including title,
description, conditions, interventions, locations, etc. Terms in this field are
searched the same as Basic Search.
Recruitment:
Limits search results to studies that are open or closed. New volunteers may be
able to participate in open studies, but not closed studies.
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Study Results:Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Values are color coded (as shown) in the search results.
Limits search results based on whether the study has results or not:
Study Type:
All Studies,
Studies With Results, or
Studies Without Results
The inclusion of Study Results is a new feature of ClinicalTrials.gov.
Only a few studies have results available.Studies With Results, or
Studies Without Results
Limits search results to any of the following study types:
Conditions:
Interventional,
Observational, or
Expanded Access
Observational, or
Expanded Access
Performs a search on fields describing the diseases or conditions being studied.
Interventions:
Performs a search on fields listing the drugs or interventions being studied.
Outcomes Measures:
Performs a search on fields listing the outcome measures used to quantify study results.
Sponsor/Collaborators:
Performs a search on fields listing the sponsor and collaborators of a study.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Sponsor (Lead):
Performs a search on the sponsor field of a study.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Study IDs:
Performs a search on fields listing ID numbers.
Country/State:
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state (e.g., United States, Alabama).
Location Terms:
Finds studies in specific locations such as a city (Los Angeles) or facility (Mayo Clinic).
Not all studies include this level of detail, but if they do, this will find them.
Gender:
Limits search results to those studies that accept female or male participants.
Age Group:
Limits search results to those studies that include at least one of the specified age
ranges. More than one age group can be selected.
Phase:
Limits search results to studies that are labeled with at least one of the specified
phases. More than one Phase can be selected.
Funded By:
Limits search results to studies that have at least one sponsor of the specified types.
More than one sponsor type can be selected.
Safety Issue:
Limits search results to studies that have at least one outcome measure designated as a safety issue.
First Received:
Limits search results to studies that were received by clinical trials within a
specified date range. The "From" or "To" field can be left blank.
Last Updated:
Limits search results to studies that were modified within a
specified date range. The "From" or "To" field can be left blank.
Refine Search:
Searches display a list of studies found (List Results tab). If you are not content with
the search results, click on the Refine Search tab at the top of the list to modify your
search.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
When you are done making changes, click Search to display the new results.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
heart attack
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
When you are done making changes, click Search to display the new results.
Search Expressions:
Use AND (all upper case) to find study records that contain all terms connected by AND.
For example:
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.
For example:
prostate cancer AND radiation
heart disease AND stroke AND California
heart disease AND stroke AND California
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Aspirin OR ibuprofen
heart disease OR heart attack
heart disease OR heart attack
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Immunodeficiency NOT AIDS
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
prostate cancer AND NOT ( radiation OR homeopathic remedies )
( heart disease OR heart attack ) AND ( stroke OR clot )
( heart disease OR heart attack ) AND ( stroke OR clot )
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
Ear, Nose, and Throat Conditions
is the expression
( Ear OR Nose OR Throat ) AND Conditions
Fortunately, search will do a pretty good job of finding the right studies either way.To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.